Assessment of risk factors in coronary patients being followed by cardiologists: Control of risk factors in coronary patients

Preventive Cardiology

Volumn 6, Issue 3, 2003, Pages 122-127

  Ladeia, Ana Marice ^a   Guimarães, Armênio C ^b,c  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Centro Medico Garibaldi   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; BODY MASS; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; WEIGHT HIP RATIO;

EID: 0038080224     PISSN: 1520037X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1520-037X.2003.01967.x     Document Type: Article

References (21)

1. EUROASPIRE Study Group. EUROASPIRE - A European Society of Cardiology survey of secondary prevention of coronary heart disease. Eur Heart J. 1997;18:1569-1582.
2. Ladeia AM, Guimaraes AC, Lima JC. Lipid profile and coronary heart disease. Arq Bras Cardiol. 1994;63:101-106.
3. Forti N, Fukushima J, Giannini SD. Lipid profile vs. coronary angiographic aspects in different Brazilian regions. Arq Bras Cardiol. 1997;68:333-342.
4. Cohen MV, Byme MJ, Levine B, et al. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary heart disease. Circulation. 1991;83:1294-1304.
5. Stafford RS, Blumenthal D, Pasternak RC. Variations in cholesterol management practices of US physicians. J Am Coll Cardiol. 1997;29:139-146.
6. Frolkis PJ, Zyzansky SJ, Schwartz JM, et al. Physicians noncompliance with the 1993 National Cholesterol Education Program (NECP II) guidelines. Circulation. 1998;98: 851-855.
7. Ladeia AM, Guimarães AC. Cardiologist's attitude toward secondary prevention of coronary heart disease in Bahia, Brazil. CVD Prevention. 1999;2:273-280.
8. National Cholesterol Education Program. Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. US Department of Health and Human Services. Public Health Services. National Institutes of Health. January 1989. NIH Publication No. 89-2925.
9. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1333-1448.
10. Joint National Committee. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health, National Heart, Lung, and Blood Institute. November 1997. NIH Publication No. 98-4080.
11. Reeder BA, Angel A, Ledoux M, et al. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. CMAJ. 1992;1:37-47.
12. Larsson B, Bengtsson C, Bjorntorp P, et al. Is abdominal body fat distribution a major explanation for sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol. 1992;135:266-273.
13. Prabhakaran D, Shah P, Joshi M, et al. Obesity and body fat distribution in relation to CHD risk factors. Can J Cardiol. 1997;13(suppl B):72B.
14. Friedwald WT, Levy RI, Fredrickson DS. Estimation of concentrations of low density cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chem. 1972;18: 499-502.
15. Guimarães AC, Lima M, Mota E, et al., for the National Cholesterol Group. The cholesterol level of a selected Brazilian salaried population: biological and socioeconomic influences. CVD Prevention. 1998;1:306-317.
16. Pearson T, Fuster V. Executive Summary. 27th Bethesda Conference: matching the intensity of risk factors management with hazard for coronary disease events. J Am Coll Cardiol. 1996;27:961-963.
17. Second Brazilian Consensus on Dyslipidemia. Detection, evaluation and treatment. Brazilian Society of Cardiology. Arq Bras Cardiol. 1996;67(suppl):1-16.
18. Smith SC Jr, Blair SN, Criqui MH, et al. AHA Consensus Panel Statement. Preventing heart attack and death in patients with coronary disease. J Am Coll Cardiol. 1995;26: 292-294.
19. Frolkis JP, Blackburn GG, Pearce GL, et al. Usefulness of providing physicians the results of risk factor assessments and treatment recommendations at discharge after coronary artery bypass grafting. Am J Cardiol. 2000;86:455-457.
20. Hulley S, Grady D, Bush T, et al., for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women.JAMA. 1998;280.605-613.
21. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288: 321-333.